Name | RIDR-PI-103 |
---|
Description | RIDR-PI-103 is a reactive oxygen species (ROS)-induced drug release prodrug with a self-cyclizing moiety linked to a pan-PI3K inhibitor (PI-103). Doxorubicin and RIDR-PI-103 shows a synergistic effect in MDA-MB-361 and MDA-MB-231 cells to inhibit cancer cell proliferation[1][2]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C27H25N7O4 |
---|---|
Molecular Weight | 511.53 |